https://www.selleckchem.com/pr....oducts/KU-0063794.ht
006). The median dose of AZA in both groups was 2.1 mg/kg per day. We observed eight adverse events in seven patients from the IFX + AZA group. Adverse effects were less common in the AZA group (P = 0.002). Combined therapy (IFX + AZA) was more effective in achieving MH in pediatric CD than treatment with AZA alone. Combined therapy (IFX + AZA) was more effective in achieving MH in pediatric CD than treatment with AZA alone.Philosophical inquiries in nursing are useful for analysing and critiquing existing practices, exploring contex
Like
Comment
Share
